Developer docs
API playgroundTry for free, no card

Search company profiles

MedicSense

Full company profile

uuid003kkv7

Namestring
MedicSense
Legal namestring
IQVIA Inc.
Websiteurl
medicsense.com
Company typeenum
Public
Founded yearstring
-
Descriptiontext

MedicSense is presented in firmographic data as a clinical and regulatory affairs company headquartered in Petah Tiqva, Israel, with 11–50 employees. The substantive content and product detail available, however, describe the operations of IQVIA MedTech, a sub-brand of IQVIA Inc. (NYSE: IQV), the publicly traded global healthcare data and clinical research services company formed from the 2018 merger of Quintiles and IMS Health. This creates an unresolved identity conflict: the entity described at scale (2,500+ experts, 80+ countries, 585+ device studies, 9,800+ activated sites) is materially larger than the firmographic MedicSense profile suggests. The analysis below is grounded in the detailed content block, which characterizes the business.

IQVIA MedTech operates as an integrated Contract Research Organization (CRO) for the medical device, in vitro diagnostic (IVD), and digital health sectors. Core service modules cover study planning and design, clinical study operations, data management and biostatistics, and quality and safety — supported by regulatory strategy and IRB/EC submissions, contracts and budgets, site management, patient recruitment and engagement, clinical trial reimbursement and billing, and risk-based monitoring. The platform extends through post-market real-world evidence generation and observational registries. Technology components include a proprietary Electronic Data Capture (EDC) system, proprietary feasibility and site-selection data assets, and what the company describes as "Healthcare-Grade AI" analytics for clinical data processing and decision support. The 2023 acquisition of MCRA (Medical Device Regulatory Consulting Associates) was integrated as a sub-brand providing specialized regulatory consulting for FDA submissions and EU MDR compliance.

The business model is professional services revenue from enterprise MedTech sponsors under multi-year contracts, delivered via flexible full-service or functional service provider (FSP) engagement models. Pricing is quote-based and not publicly disclosed. Go-to-market is direct enterprise field sales across four regional clusters (Americas, Europe, Asia & Oceania, Middle East & Africa), supported by thought-leadership content, whitepapers, webinars, and case-study marketing. The primary customer segment is medical device companies; IVD and digital health companies are secondary. Competitive positioning rests on 40+ years of regulatory expertise, 15+ therapeutic areas, global scale across 80+ countries, and the integrated regulatory-clinical-commercial offering assembled through MCRA.

Short descriptiontext

MedicSense is presented as an Israel-based clinical and regulatory affairs firm (11–50 employees), though available content describes IQVIA MedTech, a global CRO sub-brand of IQVIA Inc. providing end-to-end clinical trial, regulatory, and quality services for medical device, IVD, and digital health sponsors across 80+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPetah Tiqva, Israel
HQ citystring
Petah Tiqva
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, regulatory affairs consulting, medical device CRO, clinical trial management, MedTech regulatory compliance
Industry3 codes
PRIMARYHLAGAOAA
Clinical Operations & Monitoring FSP (CRA/CTM/Start-up)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAC
Medical Writing & Clinical Documentation FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAG
Medical Affairs, Scientific Communications & HEOR FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Health Services8000
Product category
Clinical Research Organization (CRO) Services
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Research Services
TypeProfessional Services
Description

Comprehensive clinical trial management including study planning and design, clinical study operations, data management and biostatistics, quality and safety services, and study phases from feasibility through post-market evidence generation

iqvia.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Custom enterprise engagements
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based / Not publicly disclosed; flexible engagement models from full-service to functional service provider (FSP) arrangements

iqvia.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

MedicSense is a clinical and regulatory affairs company providing end-to-end clinical research solutions for medical device, IVD, and digital health companies. The company delivers services spanning study planning and design, clinical study operations, data management and biostatistics, quality and safety oversight, regulatory strategy, and real-world evidence generation across the full device lifecycle. It operates with flexible engagement models ranging from full-service to functional service provider (FSP) arrangements.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Exceeded patient enrollment goals six months ahead of schedule (cardiovascular device case study)
Product overview1 text field

IQVIA MedTech is an integrated CRO (Contract Research Organization) platform offering end-to-end clinical research solutions for medical devices, IVDs, and digital health technologies. The portfolio combines Study Planning & Design, Clinical Study Operations, Data Management & Biostatistics, and Quality & Safety as core service modules, supported by Regulatory Strategy, Contracts & Budgets, Site Management, Patient Recruitment & Engagement, Reimbursement & Billing, and Monitoring services. The platform delivers clinical development across the full device lifecycle—from early feasibility and pilot trials through pivotal trials and post-market evidence generation—including real-world evidence and observational registries. MCRA (integrated via acquisition) provides specialized regulatory consulting for FDA submissions and EU MDR compliance.

Product and service5 records
1Clinical Research Services for MedTech
CategoryClinical Research Organization (CRO)
2Regulatory Strategy & Submissions
CategoryRegulatory Affairs Consulting
3Reimbursement & Market Access
CategoryReimbursement / Market Access Services
4Quality Assurance & Compliance
CategoryQuality Assurance / Compliance Consulting
5MedTech Commercialization Services
CategoryCommercialization Services
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1MCRA (Musculoskeletal Clinical Regulatory Advisories)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

MCRA is now part of IQVIA MedTech, bringing together regulatory expertise with advanced analytics, technology, and global reach. The partnership provides strategic guidance and operational support for FDA submissions, EU MDR compliance, and global market entry.

iqvia.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1IQVIA MedTech
TypeBroad incumbent
Description

IQVIA MedTech is the global CRO sub-brand under which much of the enriched data is described, offering end-to-end clinical research, regulatory affairs, and market access for medical devices, IVDs, and digital health. It is directly comparable on therapeutic breadth, regulatory depth, and global site footprint, and is the apparent platform affiliation for MedicSense.

2ICON plc
TypeDirect peer
Description

ICON plc is one of the largest global CROs, providing clinical research services across all major therapeutic areas including medical devices. Comparable on enterprise clinical operations, global site management, and FSP-style engagements targeting large device and diagnostic sponsors.

3Medpace Holdings
TypeDirect peer
Description

Medpace is a mid-size, therapeutically focused CRO with strong medical device and cardiovascular capabilities, often competing for the same full-service and FSP engagements. Comparable business model (full-service clinical operations with embedded therapeutic expertise) and target customer (mid-cap medical device innovators).

4NAMSA
TypeDirect peer
Description

NAMSA is the leading CRO specializing exclusively in medical devices, IVDs, and combination products, with regulatory consulting and biological safety services. Highly comparable as a MedTech-specialist peer competing for device sponsors needing deep regulatory and clinical evidence generation.

5Premier Research
TypeDirect peer
Description

Premier Research is a specialized CRO focused on medical devices, diagnostics, and rare disease, with strong regulatory affairs capabilities. Comparable on MedTech vertical focus, regulatory depth, and small-to-mid-cap device sponsor customer base.

6Parexel International
TypeBroad incumbent
Description

Parexel is a large global CRO with established medical device and biopharma clinical research services, including FSP offerings. Comparable on full-service clinical operations and FSP delivery models, though its biopharma focus is more dominant than MedicSense's.

7Worldwide Clinical Trials
TypeDirect peer
Description

Worldwide Clinical Trials is a mid-size global CRO providing clinical operations, biometrics, and regulatory services across multiple therapeutic areas including MedTech-adjacent indications. Comparable on mid-market CRO positioning and FSP/full-service flexibility.

8Clario
TypeEmerging player
Description

Clario provides clinical trial technology and endpoint data services, including eCOA, imaging, and respiratory solutions used heavily in MedTech and device trials. Comparable as a clinical evidence technology and services partner for device sponsors, though it focuses on endpoints rather than full-service operations.

9BioClin (formerly Novella Clinical)
TypeDirect peer
Description

BioClin is a CRO focused specifically on emerging and mid-size medical device and oncology companies, providing full-service clinical operations. Comparable on MedTech specialization and customer profile of smaller device innovators needing outsourced clinical execution.

10CardioMed (CMIC)
TypeRegional player
Description

CMIC is a leading Japanese CRO with growing global operations offering clinical research and regulatory services to medical device and pharma sponsors. Comparable on full-service clinical and regulatory offerings, and is a regional peer from a non-Western hub perspective relative to MedicSense's Israel base.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MedicSense

Clinical Research Organization (CRO) Servicesmedicsense.com

MedicSense is presented as an Israel-based clinical and regulatory affairs firm (11–50 employees), though available content describes IQVIA MedTech, a global CRO sub-brand of IQVIA Inc. providing end-to-end clinical trial, regulatory, and quality services for medical device, IVD, and digital health sponsors across 80+ countries.

What MedicSense does

MedicSense is presented in firmographic data as a clinical and regulatory affairs company headquartered in Petah Tiqva, Israel, with 11–50 employees. The substantive content and product detail available, however, describe the operations of IQVIA MedTech, a sub-brand of IQVIA Inc. (NYSE: IQV), the publicly traded global healthcare data and clinical research services company formed from the 2018 merger of Quintiles and IMS Health. This creates an unresolved identity conflict: the entity described at scale (2,500+ experts, 80+ countries, 585+ device studies, 9,800+ activated sites) is materially larger than the firmographic MedicSense profile suggests. The analysis below is grounded in the detailed content block, which characterizes the business.

IQVIA MedTech operates as an integrated Contract Research Organization (CRO) for the medical device, in vitro diagnostic (IVD), and digital health sectors. Core service modules cover study planning and design, clinical study operations, data management and biostatistics, and quality and safety — supported by regulatory strategy and IRB/EC submissions, contracts and budgets, site management, patient recruitment and engagement, clinical trial reimbursement and billing, and risk-based monitoring. The platform extends through post-market real-world evidence generation and observational registries. Technology components include a proprietary Electronic Data Capture (EDC) system, proprietary feasibility and site-selection data assets, and what the company describes as "Healthcare-Grade AI" analytics for clinical data processing and decision support. The 2023 acquisition of MCRA (Medical Device Regulatory Consulting Associates) was integrated as a sub-brand providing specialized regulatory consulting for FDA submissions and EU MDR compliance.

The business model is professional services revenue from enterprise MedTech sponsors under multi-year contracts, delivered via flexible full-service or functional service provider (FSP) engagement models. Pricing is quote-based and not publicly disclosed. Go-to-market is direct enterprise field sales across four regional clusters (Americas, Europe, Asia & Oceania, Middle East & Africa), supported by thought-leadership content, whitepapers, webinars, and case-study marketing. The primary customer segment is medical device companies; IVD and digital health companies are secondary. Competitive positioning rests on 40+ years of regulatory expertise, 15+ therapeutic areas, global scale across 80+ countries, and the integrated regulatory-clinical-commercial offering assembled through MCRA.

MedicSense firmographics

Firmographics
Name
MedicSense
Legal name
IQVIA Inc.
Website
https://medicsense.com
Company type
Public
Operating status
Operating
Headcount range
11–50 employees
Short description
MedicSense is presented as an Israel-based clinical and regulatory affairs firm (11–50 employees), though available content describes IQVIA MedTech, a global CRO sub-brand of IQVIA Inc. providing end-to-end clinical trial, regulatory, and quality services for medical device, IVD, and digital health sponsors across 80+ countries.
Ownership category
akta.pro rank

MedicSense industry classification

Industry
Product category
Clinical Research Organization (CRO) Services
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLAGAOAA
Clinical Operations & Monitoring FSP (CRA/CTM/Start-up)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAC
Medical Writing & Clinical Documentation FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAG
Medical Affairs, Scientific Communications & HEOR FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

  • Clinical research services
  • Regulatory affairs consulting
  • Medical device CRO
  • Clinical trial management
  • MedTech regulatory compliance

Where MedicSense is headquartered

Location

Headquarters

HQ city
Petah Tiqva
HQ country
Israel
HQ region
Middle East

Offices1 record

Markets served

MedicSense business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Clinical Research Services: Comprehensive clinical trial management including study planning and design, clinical study operations, data management and biostatistics, quality and safety services, and study phases from feasibility through post-market evidence generation

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom enterprise engagements

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

MedicSense product offering

Product offering

Core offering

MedicSense is a clinical and regulatory affairs company providing end-to-end clinical research solutions for medical device, IVD, and digital health companies. The company delivers services spanning study planning and design, clinical study operations, data management and biostatistics, quality and safety oversight, regulatory strategy, and real-world evidence generation across the full device lifecycle. It operates with flexible engagement models ranging from full-service to functional service provider (FSP) arrangements.

Product overview

IQVIA MedTech is an integrated CRO (Contract Research Organization) platform offering end-to-end clinical research solutions for medical devices, IVDs, and digital health technologies. The portfolio combines Study Planning & Design, Clinical Study Operations, Data Management & Biostatistics, and Quality & Safety as core service modules, supported by Regulatory Strategy, Contracts & Budgets, Site Management, Patient Recruitment & Engagement, Reimbursement & Billing, and Monitoring services. The platform delivers clinical development across the full device lifecycle—from early feasibility and pilot trials through pivotal trials and post-market evidence generation—including real-world evidence and observational registries. MCRA (integrated via acquisition) provides specialized regulatory consulting for FDA submissions and EU MDR compliance.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Research Services for MedTech
  • Regulatory Strategy & Submissions
  • Reimbursement & Market Access
  • Quality Assurance & Compliance
  • MedTech Commercialization Services

Quantifiable outcome

  • Exceeded patient enrollment goals six months ahead of schedule (cardiovascular device case study)

Companies that use MedicSense

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

MedicSense technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

MedicSense partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • MCRA (Musculoskeletal Clinical Regulatory Advisories)coreStrategic or Co-development PartnerMCRA is now part of IQVIA MedTech, bringing together regulatory expertise with advanced analytics, technology, and global reach. The partnership provides strategic guidance and operational support for FDA submissions, EU MDR compliance, and global market entry.

Scale indicators5 records

Recent moves5 records

Expansion highlights6 records

MedicSense competitors and assessment

Company assessment

Broad incumbents

  • IQVIA MedTech: IQVIA MedTech is the global CRO sub-brand under which much of the enriched data is described, offering end-to-end clinical research, regulatory affairs, and market access for medical devices, IVDs, and digital health. It is directly comparable on therapeutic breadth, regulatory depth, and global site footprint, and is the apparent platform affiliation for MedicSense.
  • Parexel International: Parexel is a large global CRO with established medical device and biopharma clinical research services, including FSP offerings. Comparable on full-service clinical operations and FSP delivery models, though its biopharma focus is more dominant than MedicSense's.

Direct peers

  • ICON plc: ICON plc is one of the largest global CROs, providing clinical research services across all major therapeutic areas including medical devices. Comparable on enterprise clinical operations, global site management, and FSP-style engagements targeting large device and diagnostic sponsors.
  • Medpace Holdings: Medpace is a mid-size, therapeutically focused CRO with strong medical device and cardiovascular capabilities, often competing for the same full-service and FSP engagements. Comparable business model (full-service clinical operations with embedded therapeutic expertise) and target customer (mid-cap medical device innovators).
  • NAMSA: NAMSA is the leading CRO specializing exclusively in medical devices, IVDs, and combination products, with regulatory consulting and biological safety services. Highly comparable as a MedTech-specialist peer competing for device sponsors needing deep regulatory and clinical evidence generation.
  • Premier Research: Premier Research is a specialized CRO focused on medical devices, diagnostics, and rare disease, with strong regulatory affairs capabilities. Comparable on MedTech vertical focus, regulatory depth, and small-to-mid-cap device sponsor customer base.
  • Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-size global CRO providing clinical operations, biometrics, and regulatory services across multiple therapeutic areas including MedTech-adjacent indications. Comparable on mid-market CRO positioning and FSP/full-service flexibility.
  • BioClin (formerly Novella Clinical): BioClin is a CRO focused specifically on emerging and mid-size medical device and oncology companies, providing full-service clinical operations. Comparable on MedTech specialization and customer profile of smaller device innovators needing outsourced clinical execution.

Emerging players

  • Clario: Clario provides clinical trial technology and endpoint data services, including eCOA, imaging, and respiratory solutions used heavily in MedTech and device trials. Comparable as a clinical evidence technology and services partner for device sponsors, though it focuses on endpoints rather than full-service operations.

Regional players

  • CardioMed (CMIC): CMIC is a leading Japanese CRO with growing global operations offering clinical research and regulatory services to medical device and pharma sponsors. Comparable on full-service clinical and regulatory offerings, and is a regional peer from a non-Western hub perspective relative to MedicSense's Israel base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

MedicSense social profiles

Digital presence

MedicSense financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MedicSense leadership team

Management profile

Number of profiles

Profiles1 record

MedicSense subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

MedicSense funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MedicSense M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MedicSense

What does MedicSense do?

MedicSense is a clinical and regulatory affairs company providing end-to-end clinical research solutions for medical device, IVD, and digital health companies. The company delivers services spanning study planning and design, clinical study operations, data management and biostatistics, quality and safety oversight, regulatory strategy, and real-world evidence generation across the full device lifecycle. It operates with flexible engagement models ranging from full-service to functional service provider (FSP) arrangements.

Is MedicSense a public or private company?

MedicSense is a public company. It is classified as founder individual operated bootstrapped and is currently operating.

When was MedicSense founded?

MedicSense was founded in -1. It employs 11 to 50 people.

Where is MedicSense based?

MedicSense is headquartered in Petah Tiqva, Israel, in the Middle East region.

How does MedicSense make money?

One revenue line is on record: clinical Research Services.

Who are MedicSense's main competitors?

Broad incumbents on record are IQVIA MedTech and Parexel International. Direct peers are ICON plc, Medpace Holdings, NAMSA, Premier Research, Worldwide Clinical Trials and BioClin (formerly Novella Clinical). Clario is listed as an emerging player. CardioMed (CMIC) is listed as a regional player.

Does MedicSense have an API?

No public API is recorded for MedicSense.

What industry is MedicSense in?

MedicSense's product category is Clinical Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAOAA, Clinical Operations & Monitoring FSP (CRA/CTM/Start-up), with a secondary code of HLAGAOAC, Medical Writing & Clinical Documentation FSP. Its NAICS code is 5417 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals